3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Breast
1
Conditions
Leukemia, Myeloid, Acute
272
Leukemia
194
Precursor Cell Lymphoblastic Leukemia-Lymphoma
131
Lymphoma
108
Congenital Abnormalities
68
Myelodysplastic Syndromes
63
Leukemia, Myelomonocytic, Acute
60
Leukemia, Monocytic, Acute
58
Leukemia, Erythroblastic, Acute
56
Leukemia, Megakaryoblastic, Acute
54
Lymphoma, Non-Hodgkin
51
Burkitt Lymphoma
44
Lymphoma, Mantle-Cell
42
Lymphoma, Large B-Cell, Diffuse
41
Lymphoma, Follicular
33
Leukemia, Myelomonocytic, Chronic
28
Anemia, Refractory, with Excess of Blasts
27
Hodgkin Disease
26
Recurrence
25
Lymphoma, Large-Cell, Immunoblastic
25
Leukemia, Lymphocytic, Chronic, B-Cell
25
Blast Crisis
24
Leukemia, Eosinophilic, Acute
19
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
18
Myeloproliferative Disorders
17
Leukemia, Basophilic, Acute
17
Lymphoma, B-Cell, Marginal Zone
16
Leukemia, Promyelocytic, Acute
16
Leukemia, Myeloid, Chronic-Phase
15
Leukemia, Myeloid, Accelerated Phase
14
Interventions
Trastuzumab
350
Paclitaxel
334
Cyclophosphamide
315
Docetaxel
291
Capecitabine
181
Doxorubicin
180
Letrozole
166
Tamoxifen
145
Bevacizumab
124
Fulvestrant
118
Carboplatin
118
exemestane
111
Lapatinib
111
Anastrozole
111
Radiotherapy
105
Epirubicin
104
Gemcitabine
97
palbociclib
84
Exercise
78
Vinorelbine
77
Fluorouracil
77
Surveys and Questionnaires
71
pertuzumab
67
Filgrastim
64
Albumin-Bound Paclitaxel
64
eribulin
55
Magnetic Resonance Spectroscopy
55
Everolimus
52
Blood Specimen Collection
51
Zoledronic Acid
50
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Breast Neoplasms
×
Cytarabine
×
Clear all
NCT01645839
2019-06-12
DEPOSEIN
Centre Oscar Lambret
Phase 3
Completed
74 enrolled